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The initial processes of platelet activation by platelet-activating factor (PAF) were observed by stopped-flow 
light scattering and fluorometry. The binding of PAF to rabbit platelets did not change the membrane fluid- 
ity, though it caused the removal of calcium from internal stores and induced concomitantly platelet shape 
changes. These results were quite in contrast to those by thrombin and ADP activation, where the mem- 
brane fluidity increased before the calcium release from the internal stores. The increased membrane fluidity 
in the latter system seemed to be used to transmit an external signal to a GTP-binding protein. 
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1. INTRODUCTION 
In various cells, the binding of ligands to their 
specific receptors induces an increase in cytosolic 
calcium concentration. This rise in cytosolic 
calcium is suggested to follow the breakdown of 
phosphatidylinositol bisphosphate into diacyl- 
glycerol and inositol trisphosphate. The latter is 
known to cause release of calcium from intra- 
cellular stores [l-4]. The increase in the intra- 
cellular level of calcium and the released 
diacylglycerol, which stimulates protein phosphor- 
ylation, are known to mediate the subsequent 
physical responses [l-4]. 
To understand the physical aspects of such kinds 
of signal transfer, we have recently studied the in- 
itial transmembrane vents involved in platelet ac- 
tivation by thrombin and ADP using stopped-flow 
photometry [5,6]. From these experiments we 
found that the binding of the ligands to their mem- 
brane receptors increased the platelet membrane 
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fluidity before the release of calcium from in- 
tracellular stores [5,6]. Therefore, it seems that the 
rapid rise of the membrane fluidity is used for in- 
itial signal transduction, i.e. to transmit a signal to 
a GTP-binding protein [7,8] or to a phospholipase 
C which breaks down phosphatidylinositol 
bisphosphate into diacylglycerol and inositol 
trisphosphate [11. 
Here, we have studied the initial processes of 
platelet activation by a platelet-activating factor 
(PAF) using stopped-flow spectrophotometry. The 
binding of PAF to rabbit blood platelets induced 
the release of calcium from intracellular stores as 
did the binding of thrombin (or ADP). Contrary to 
thrombin (or ADP), however, PAF did not change 
the platelet membrane fluidity at all. These obser- 
vations lead us to discuss the relationship between 
the initial membrane fluidity change and cell 
signaling. 
2. MATERIALS AND METHODS 
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sn-glycero-3-phosphorylcholine (PAF) was kindly 
provided by Professor Keizo Inoue (University of 
Tokyo). 
Chlortetracycline was incorporated into platelets 
by incubating 9 x 10’ cells/ml platelet suspension 
with 10pM chlortetracycline for 30 min at 25°C. 
Pyrene was incorporated into platelets by in- 
cubating 1.4 x 10’ cells/ml platelet suspension 
with 10pM pyrene for 30 min at 25°C. The 
platelets were then washed with Ca2+-free Tyrode 
solution (10 mM Tris-HCl, 137 mM NaCl, 2.6 
mM KCl, 0.1% glucose, pH 7.3) and resuspended 
in the same buffer for fluorescence measurements. 
Fluorescence spectra were observed using a 
Hitachi model 650- 10s fluorescence spec- 
trophotometer. The time courses of fluorescence 
and light scattering were traced with a Union 
Giken RA-401 stopped-flow spectrophotometer in 
combination with an RA-450 microcomputer 
system [ 10,111. The dead time of this instrument is 
0.5 ms. We used a Hoya Y46 cut filter (which 
allows the emitted light of wavelength longer than 
460 nm to enter the detector) in the 
chlortetracycline and pyrene fluorescence 
measurements. Light scattering measurement was 
made at an angle of 90” from the incident beam, 
whose wavelength was set at 500 nm. 
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Fig. 1. Stopped-flow spectrophotometry traces indicating 
effects of platelet-activating factor on rabbit platelets. 
Platelet concentration was 7.0 x 10’ cells/ml and PAF 
concentration was 8.0 nM after mixing. Temperature 
was 25°C. (a) Light scattering intensity (90”) at 500 nm. 
(b) Fluorescence from chlortetracycline-labeled p atelets 
was monitored on exciting at 400 nm and by observing 
through a cut filter which allows light of wavelength 
longer than 460 nm to enter the detector. 
3. RESULTS 
3.1. Platelet shape change by PAF 
When a platelet suspension (final 7 x 10’ 
platelets) was mixed with PAF (final 8.0 nM) by a 
stopped-flow spectrophotometer, the time- 
dependent light scattering (90”) was observed as 
shown in fig.la. This kind of change in light scat- 
tering was also found in the binding of thrombin 
(1 U/ml) or ADP (0.1 mM) to platelets [5,6]. The 
later phase of the light scattering changes described 
here is consistent with the results of conventional 
light scattering experiments [12,13]. Our new fin- 
ding is the occurrence of a lag period. That is, after 
a short lag period (5 s at 25”(Z), the light scattering 
was abruptly decreased which reflected the platelet 
shape changes [5,6,12,13]. 
similar to what was observed in the light scattering 
measurement. The chlortetracycline fluorescence 
decrease was considered to be caused by calcium 
release from internal stores into the cytoplasm 
[5,6,14,15]. When 5 mM EDTA was added to the 
external medium to prevent calcium influx into 
platelets, the chlortetracycline fluorescence 
decrease was still observed. This indicates that the 
chlortetracycline fluorescence change in fig. 1 b was 
attributable to intracellular calcium mobilization 
and not to calcium influx [16]. The release of 
calcium from internal stores occurred con- 
comitantly with the platelet shape changes. Here, 
thrombin or ADP also induced similar changes in 
chlortetracycline fluorescence in platelets [5,6]. 
3.3. Effect on membrane fluidity 
3.2. Intracellular calcium release by PAF During the 5 s lag period (at 25”C), a rapid in- 
On mixing with PAF, the fluorescence intensity crease in platelet membrane fluidity was observed 
of the chlortetracycline-labelled platelets decreased by the use of pyrene excimer fluorescence when 
after a 5 s lag period at 25°C (fig.lb), which was platelets were mixed with thrombin (or ADP) 
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Fig.2. Stopped-flow fluorometry traces indicating 
effects of ligands on platelet membrane fluidity. Rabbit 
platelet concentration was 7.0 X 10’ cells/ml. 
Temperature was 25°C. Fluorescence from pyrene- 
labeled platelets was monitored on exciting at 340 nm 
and by observing through a cut filter which allows light 
of wavelength longer than 460 nm to enter the detector. 
(a) Effects of thrombin (1 U/ml) on the fluorescence of 
pyrene-labeled platelets. (b) Effects of platelet-activating 
factor (8.0 nM) on the fluorescence of pyrene-labeled 
platelets. 
[5,6]. Fluorescence spectra of pyrene embedded in 
platelets membranes showed monomer fluores- 
cence peaks around 390 nm and a broad excimer 
fluorescence peak around 480 nm [5,6,17,18]. 
After binding of thrombin (1 U/ml), the excimer 
fluorescence in platelets increased gradually 
without a lag period (fig.2a) [5,6]. However, the 
binding of PAF to platelets did not change the 
membrane fluidity at all as seen in fig.2b, although 
PAF induced both the removal of the intracellular 
calcium and platelet shape changes. 
4. DISCUSSION 
The present experiment showed that the binding 
of PAF to platelets did not change the platelet 
membrane fluidity, although it caused the removal 
of calcium from the internal stores, However, the 
binding of thrombin or ADP increased the platelet 
membrane fluidity before the calcium release from 
internal stores. In addition, our recent experiments 
showed that ligand binding to specific cell surface 
receptors, for example interleukin 2 receptors, also 
increased the membrane fluidity before the 
calcium release from internal stores [9]. Thus, the 
increased membrane fluidity now in question may 
be used for transmembrane signaling, i.e. to 
transmit a signal from the cell surface receptors to 
a GTP-binding protein or to perturb the mem- 
brane sufficiently to make phosphatidylinositol 
bisphosphate accessible to phospholipase C. We 
cannot say which process really occurred at pre- 
sent. It is plausible, however, that the membrane 
fluidity increases are used to transmit a signal to 
the GTP-binding protein, because PAF which did 
not cause an increase of platelet membrane fluidity 
is known to induce phospholipase C activation 
WI. 
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